Wearable Monitoring and Therapy Systems

Auricular Health Monitoring and Brain-Computer Interface (BCI) systems that utilize ear-based sensors for continuous physiological tracking and neural signal processing.

  1. General Details

    This strategic patent portfolio covers next-generation wearable medical devices, digital health systems, neurotechnology, and AI-driven health monitoring platforms designed for continuous, non-invasive monitoring through the ear. The patented technologies utilize advanced in-ear sensors to capture clinical-grade physiological signals, including EEG, ECG, EOG, pulse oximetry, and blood flow data, enabling more accurate monitoring than traditional wrist-based wearables. The portfolio includes intellectual property for multiple high-growth healthcare and consumer technology markets, including wearable health monitoring, sleep monitoring, brain-computer interface (BCI), neuromodulation, migraine management, cardiac monitoring, and digital therapeutics.

    Key applications include in-ear health monitoring systems for tracking brain activity, heart activity, eye movement, oxygen levels, and sleep quality; wearable sleep apnea detection and sleep stage monitoring; automated detection and treatment systems for neurological and neuropsychiatric disorders; migraine and cluster headache prediction and therapy; and closed-loop cardiac arrhythmia monitoring with automated neuromodulation. The technologies are designed in compact earbud-style and hearing-aid-style wearable formats suitable for continuous ambulatory use, remote patient monitoring, and at-home healthcare applications. The portfolio also includes patented brain-computer interface functionality for robotics, gaming, assistive mobility devices, and hands-free device control.

  2. Patent Portfolio

    The IP and assets available for sale include:

    •  US 12,543,961 – Auricular Health Monitoring and Brain-Computer Interface Systems (Issued: 02/10/2026).
    •  US 12,594,026 – Auricular Sleep Monitoring Systems and Ear-Canal Pulse Oximeter (Issued: 04/07/2026).
    •  US 12,642,486 – Auricular Electroencephalogram (EEG) and Automatic Remedy Systems for  Neuropsychiatric Disorders (Issued: 06/02/2026).
    •  US Application 19/637,692 – Automatic Detection-Therapy Systems for Neuropsychiatric Disorders.
    •  US Application 19/647,337 – Automatic Detection-Therapy Systems for Migraine and Cluster Headache and Neurovascular Monitoring System.
    •  US Application 19/660,889 – Automatic Detection-Therapy Systems for Cardiac Arrhythmias and Cardiovascular Monitoring System.
    • US Application 19/332,747 – Wearable Electrocardiogram (ECG) Systems and Automatic Anti-Arrhythmia Systems.
  3. Data Room Access & Additional Details

    Other Public Data Room Materials Available at VIP-3610 Public Data Room for Wearable Monitoring and Therapy Systems IP:

    • Introductory Materials
    • Patents and Applications
    • Patents and Applications File Histories
    • Patent Assignment and Ownership

    Additional Materials (available upon signing a mutual non-disclosure agreement):

    • Due Diligence Review
  4. More Information

    Pricing guidance for this transaction may be available. All parties interested in the IP above are authorized to contact Charlette Hunter at Vibrant IP, LLC at charlette@vibrantip.com and +1 404-482-3652.